Mkts

Neumora Therapeutics, Inc.

NASDAQ: NMRA
$0.37-0.02 (-5.43%)
As of Oct 30, 4:00 PM ET

Key statistics

Day range
0.350.41
52-week range
0.323.65
Today
Open0.41
Previous close0.37
Volume—
Valuation
Market cap69.00M
P/E ratio—
EPS (TTM)-1.23
Income & risk
Dividend / yield—
Beta3.11
Avg volume1.46M
Discussion

NMRA News

Stories mentioning NMRA from around the web — every one is an open thread, so give it a like or add your take.

All news →

Loading news…

Financial statements

Financial statements

As filed, straight from the 10-Q — up to 19 years of history, free, with every line item chartable.

Line itemQ1 '26Mar 31Q4 '25Dec 31Q3 '25Sep 30Q2 '25Jun 30Q1 '25Mar 31Q4 '24Dec 31Q3 '24Sep 30Q2 '24Jun 30
Income Statement
Revenue
Cost of Goods Sold
Gross Profit0.000.000.000.000.000.000.000.00
Operating Expenses
Research & Development38,59844,67040,52038,72452,15145,91260,63048,628
Sales General & Admin
Total Operating Expenses52,86458,48057,70054,04070,93662,92276,64663,822
Operating Income (Loss)(52,864)(58,480)(57,700)(54,040)(70,936)(62,922)(76,646)(63,822)
Interest Income1,2311,6853,0744,209
Interest Expense1,436
Other Expense59.00(269.00)7.00(480.00)(25.00)15.00(57.00)(24.00)
Pretax Income(53,428)(59,450)(56,755)(52,706)(67,887)(58,819)(72,494)(58,575)
Tax Provision30.000.000.0025.00105.0053.00125.00
Net Income (Loss)(53,458)(59,450)(56,755)(52,731)(67,992)(58,819)(72,547)(58,700)
Earnings Per Share (Basic)(0.30)(0.36)(0.35)(0.33)(0.42)(0.37)(0.45)(0.37)
Earnings Per Share (Diluted)(0.30)(0.36)(0.35)(0.33)(0.42)(0.37)(0.45)(0.37)
Weighted Average Shares Outstanding (Basic)179,872163,391161,838161,691161,451159,377159,576158,984
Weighted Average Shares Outstanding (Diluted)179,872163,391161,838161,691161,451159,377159,576158,984

Scroll the table sideways for older periods — the line-item column and the period header stay put. Hover a row and use the chart handle to plot it over the full history.

Key facts

About NMRA

Neumora Therapeutics, Inc. (NASDAQ: NMRA) is a stock listed on the Nasdaq Stock Market under the ticker symbol NMRA. It last traded at $0.3700 (Oct 30, 2026, 4:00 PM ET), down 5.4% on the day. That gives Neumora Therapeutics a market capitalisation of $69.0M.

Over the past 52 weeks NMRA has traded between $0.3200 and $3.65.

For the quarter ended Mar 31, 2026 it reported a net loss of $53.5M.

Last 4 quarters
Quarter endedRevenueNet income
Mar 31, 2026—-$53.5M
Dec 31, 2025—-$59.5M
Sep 30, 2025—-$56.8M
Jun 30, 2025—-$52.7M

From Neumora Therapeutics’s quarterly (10-Q) filings, in US dollars.

Latest News

Market news from around the web — every story is an open thread, so give it a like or add your take.

All news →

Loading news…